# Depigoid Birch 5000 Longterm Study in Adults and Adolescents

> **NCT01694836** · PHASE3 · COMPLETED · sponsor: **Leti Pharma GmbH** · enrollment: 634 (actual)

## Conditions studied

- Allergic Rhinitis/Rhinoconjunctivitis +-Intermittent Asthma
- Sensitization Against Betula Alba (Birch) Pollen

## Interventions

- **BIOLOGICAL:** s.c. injection

## Key facts

- **NCT ID:** NCT01694836
- **Lead sponsor:** Leti Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09-17
- **Primary completion:** 2018-07-30
- **Final completion:** 2018-07-30
- **Target enrollment:** 634 (ACTUAL)
- **Last updated:** 2019-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01694836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01694836, "Depigoid Birch 5000 Longterm Study in Adults and Adolescents". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01694836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*